Howard Vincent Kelly
Senior Executive
Mr. Kelly assists in analyzing investment opportunities and working with portfolio investments as an operator and board member.
Mr. Kelly is a senior executive with over 30 years experience in the life sciences sector. He was most recently President of Vancive medical technologies, a division of Avery Dennison Corp He has also served as the CEO of Alma Lasers Ltd. and Whatman Plc. Mr. Kelly has also held senior executive roles at Boston Scientific, Baxter Healthcare, and Texas Instruments. Earlier in his career, he was a Naval Aviator with both the active and reserve forces retiring at the rank of Commander.
Mr. Kelly holds a B.S. in bioengineering from the University of Illinois at Chicago and an MBA in international management from the University of Dallas. He is also a fellow of the British-American project. He serves on the boards of Oxyphen AG and The Hydrafacial Company.
Mr. Kelly is a senior executive with over 30 years experience in the life sciences sector. He was most recently President of Vancive medical technologies, a division of Avery Dennison Corp He has also served as the CEO of Alma Lasers Ltd. and Whatman Plc. Mr. Kelly has also held senior executive roles at Boston Scientific, Baxter Healthcare, and Texas Instruments. Earlier in his career, he was a Naval Aviator with both the active and reserve forces retiring at the rank of Commander.
Mr. Kelly holds a B.S. in bioengineering from the University of Illinois at Chicago and an MBA in international management from the University of Dallas. He is also a fellow of the British-American project. He serves on the boards of Oxyphen AG and The Hydrafacial Company.